Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Medicaid coverage by state Medicaid coverage of GLP-1 medications for weight loss is optional for states
/i.s3.glbimg.com/v1/AUTH_da025474c0c44edd99332dddb09cabe8/internal_photos/bs/2023/V/S/BfU4flT2WBycFeuWzAww/novos-remedios-obesidade.png)
We dig into: Lilly's decision to stop disclosing its Phase 1 pipeline The Camurus fluid crystal technology deal and what it means for long-acting GLP-1s Eloralintide Lilly's selective amylin agonist and potential dark horse in obesity medicine How eloralintide compares to Novo Nordisk's cagrilintide Why the future of obesity treatment is a toolbox, not a scoreboard The access crisis: prior authorizations, insurance exclusions, Medicare, and Medicaid coverage gaps Retatrutide , quintuple agonists, and what's coming out of ADA 2026 If you're on Zepbound , Wegovy , Ozempic , or any GLP-1 medication or you're waiting for the next generation of obesity drugs this episode is for you
The weight-loss benefits of these drugs have led to their prescribed use for obesity or overweight treatment
However, candidacy involves considerably more than a number on a scale
I never saw an athlete become successful by themselves
US$ 21.23
US$ 21.64
US$ 21.79
US$ 25.78
